0.5 mg tirzepatide Zepbound Injection 5 mg/0.5 mL — Mountainside Medical Tirzepatide Dosage Guide 2025: Effective

Semaglutide activates only GLP-1 receptors (not GIP), which produces slightly less dramatic weight loss on average but may come with fewer side effects for certain individuals

Some patients experience appetite reduction within weeks, while meaningful weight loss typically develops over several months

For individuals living with type 2 diabetes, research has shown that GLP-1s can be highly effective at reducing blood sugar levels and improving glycemic control

These changes also generally cause an increase in blood sugar levels

GLP-1 receptor agonists have great therapeutic potential for treating diabetes and obesity